New Edge Wealth, LLC Charles River Laboratories International, Inc. Transaction History

New Edge Wealth, LLC

  • $5.35 Billion
  • Q1 2025

A detailed history of New Edge Wealth, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, New Edge Wealth, LLC holds 21,364 shares of CRL stock, worth $3.15 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
21,364
Previous 16,961 25.96%
Holding current value
$3.15 Million
Previous $3.13 Million 2.68%
% of portfolio
0.06%
Previous 0.06%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$150.52 - $190.14 $662,739 - $837,186
4,403 Added 25.96%
21,364 $3.22 Million
Q4 2024

Feb 04, 2025
SELL
$178.58 - $220.69 $809,145 - $999,946
-4,531 Reduced 21.08%
16,961 $3.13 Million
Q3 2024

Nov 12, 2024
BUY
$187.96 - $245.29 $213,334 - $278,404
1,135 Added 5.58%
21,492 $4.23 Million
Q2 2024

Aug 01, 2024
BUY
$206.39 - $268.73 $48,295 - $62,882
234 Added 1.16%
20,357 $4.21 Million
Q1 2024

May 06, 2024
BUY
$203.52 - $273.43 $392,183 - $526,899
1,927 Added 10.59%
20,123 $5.45 Million
Q4 2023

Jan 29, 2024
BUY
$164.52 - $238.84 $214,040 - $310,730
1,301 Added 7.7%
18,196 $4.3 Million
Q3 2023

Nov 08, 2023
BUY
$194.44 - $217.61 $296,326 - $331,637
1,524 Added 9.91%
16,895 $3.31 Million
Q2 2023

Aug 09, 2023
BUY
$183.71 - $210.25 $112,981 - $129,303
615 Added 4.17%
15,371 $3.23 Million
Q1 2023

May 08, 2023
BUY
$191.89 - $259.92 $112,063 - $151,793
584 Added 4.12%
14,756 $2.98 Million
Q4 2022

Feb 14, 2023
BUY
$197.11 - $250.07 $9,855 - $12,503
50 Added 0.35%
14,172 $3.09 Million
Q3 2022

Nov 14, 2022
BUY
$182.44 - $250.54 $168,027 - $230,747
921 Added 6.98%
14,122 $2.78 Million
Q2 2022

Aug 09, 2022
BUY
$204.13 - $302.4 $1.08 Million - $1.59 Million
5,273 Added 66.51%
13,201 $2.83 Million
Q1 2022

May 10, 2022
BUY
$255.51 - $362.11 $346,727 - $491,383
1,357 Added 20.65%
7,928 $2.25 Million
Q4 2021

Jan 31, 2022
BUY
$351.38 - $448.68 $60,788 - $77,621
173 Added 2.7%
6,571 $2.48 Million
Q3 2021

Nov 12, 2021
BUY
$372.64 - $458.3 $328,295 - $403,762
881 Added 15.97%
6,398 $2.64 Million
Q2 2021

Aug 11, 2021
BUY
$294.17 - $371.65 $53,833 - $68,011
183 Added 3.43%
5,517 $2.04 Million
Q1 2021

May 13, 2021
BUY
$249.67 - $299.48 $1.11 Million - $1.33 Million
4,450 Added 503.39%
5,334 $1.55 Million
Q4 2020

May 13, 2021
BUY
$222.0 - $252.62 $196,248 - $223,316
884 New
884 $221,000

Others Institutions Holding CRL

# of Institutions
648
Shares Held
55M
Call Options Held
695K
Put Options Held
809K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.5B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track New Edge Wealth, LLC Portfolio

Follow New Edge Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email